10x Genomics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
10x Genomics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • 10x Genomics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $59.6M, a 13.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $59.6M -$9.61M -13.9% Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $60.9M -$10.2M -14.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $62.9M -$11.9M -15.9% Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $65.4M -$4.52M -6.47% Dec 31, 2023 10-Q 2024-10-29
Q3 2023 $69.2M -$1.9M -2.68% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $71M -$2.38M -3.24% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $74.7M -$942K -1.25% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $69.9M +$8.96M +14.7% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $71.1M +$10.4M +17.1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $73.4M +$19.3M +35.7% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $75.7M +$19.3M +34.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $60.9M +$13.9M +29.7% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $60.7M +$15.3M +33.8% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $54.1M +$11M +25.5% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $56.4M +$12.3M +27.9% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $47M +$47M Dec 31, 2020 10-K 2022-02-18
Q3 2020 $45.4M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $43.1M Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $44M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $0 Dec 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.